To understand the frequency of and explore potential mechanisms which underly E- to P-cadherin switching in gastric cancer, we started by analysing RNA-seq data from 43 gastric cancers to evaluate CDH1 and CDH3 mRNA expression. This evidence concerns the gene CDH3 and gastric cancer.